Compare BWIN & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWIN | RXRX |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | United States |
| Employees | 5020 | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | N/A | 2021 |
| Metric | BWIN | RXRX |
|---|---|---|
| Price | $26.22 | $3.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $30.43 | $7.50 |
| AVG Volume (30 Days) | 2.0M | ★ 19.5M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | $36.36 | $12.11 |
| Revenue Next Year | $10.82 | $82.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $15.88 | $2.77 |
| 52 Week High | $43.25 | $7.18 |
| Indicator | BWIN | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 69.92 | 56.43 |
| Support Level | $20.42 | $2.88 |
| Resistance Level | $26.74 | $4.01 |
| Average True Range (ATR) | 1.49 | 0.22 |
| MACD | 0.86 | 0.02 |
| Stochastic Oscillator | 98.08 | 77.61 |
The Baldwin Insurance Group Inc is an insurance distribution company operating in the United States. The company provides commercial risk management, employee benefits, private risk management, and personal insurance solutions. It operates through three segments: Insurance Advisory Solutions, which focuses on commercial risk management and employee benefits; Underwriting, Capacity & Technology Solutions, which includes managing general agency operations, reinsurance brokerage, captive management, and technology-enabled insurance products; and Mainstreet Insurance Solutions, which offers personal, commercial, and life and health insurance products through community-based distribution channels.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.